Acrivastine: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Acrivastine == | |||
[[File:Acrivastine.svg|thumb|right|Chemical structure of Acrivastine]] | |||
'''Acrivastine''' is a [[second-generation antihistamine]] used in the treatment of [[allergic rhinitis]] and [[urticaria]]. It is known for its rapid onset of action and is often combined with [[pseudoephedrine]] to enhance its effects in relieving nasal congestion. | |||
Acrivastine is a [[ | |||
== | == Pharmacology == | ||
Acrivastine is a [[histamine H1 receptor antagonist]], which means it works by blocking the action of [[histamine]], a substance in the body that causes allergic symptoms. Unlike first-generation antihistamines, acrivastine has minimal [[sedative]] effects, making it suitable for daytime use. | |||
== | === Mechanism of Action === | ||
Acrivastine competes with histamine for binding at the H1 receptor sites on effector cells in the [[gastrointestinal tract]], [[blood vessels]], and [[respiratory tract]]. This prevents the typical allergic response, such as [[sneezing]], [[itching]], and [[runny nose]]. | |||
Acrivastine | |||
== | == Clinical Use == | ||
== | Acrivastine is primarily used to treat symptoms associated with [[seasonal allergic rhinitis]] and [[chronic idiopathic urticaria]]. It is effective in reducing symptoms such as [[sneezing]], [[nasal congestion]], and [[itchy eyes]]. | ||
Acrivastine | |||
=== Dosage and Administration === | |||
Acrivastine is typically administered orally. The usual adult dose is 8 mg, taken up to three times a day. It is often available in combination with pseudoephedrine, marketed under various brand names. | |||
== Side Effects == | |||
Common side effects of acrivastine include [[headache]], [[drowsiness]], and [[dry mouth]]. Although it is less sedating than first-generation antihistamines, some patients may still experience drowsiness. | |||
== Contraindications == | |||
Acrivastine should not be used in individuals with known hypersensitivity to the drug or any of its components. Caution is advised in patients with [[renal impairment]] due to the drug's excretion through the kidneys. | |||
== Related Pages == | |||
* [[Antihistamine]] | * [[Antihistamine]] | ||
* [[Allergic rhinitis]] | * [[Allergic rhinitis]] | ||
* [[Urticaria]] | * [[Urticaria]] | ||
* [[ | * [[Histamine]] | ||
[[Category:Antihistamines]] | [[Category:Antihistamines]] | ||
[[Category:Allergy treatments]] | [[Category:Allergy treatments]] | ||
Latest revision as of 03:48, 13 February 2025
Acrivastine[edit]
Acrivastine is a second-generation antihistamine used in the treatment of allergic rhinitis and urticaria. It is known for its rapid onset of action and is often combined with pseudoephedrine to enhance its effects in relieving nasal congestion.
Pharmacology[edit]
Acrivastine is a histamine H1 receptor antagonist, which means it works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Unlike first-generation antihistamines, acrivastine has minimal sedative effects, making it suitable for daytime use.
Mechanism of Action[edit]
Acrivastine competes with histamine for binding at the H1 receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. This prevents the typical allergic response, such as sneezing, itching, and runny nose.
Clinical Use[edit]
Acrivastine is primarily used to treat symptoms associated with seasonal allergic rhinitis and chronic idiopathic urticaria. It is effective in reducing symptoms such as sneezing, nasal congestion, and itchy eyes.
Dosage and Administration[edit]
Acrivastine is typically administered orally. The usual adult dose is 8 mg, taken up to three times a day. It is often available in combination with pseudoephedrine, marketed under various brand names.
Side Effects[edit]
Common side effects of acrivastine include headache, drowsiness, and dry mouth. Although it is less sedating than first-generation antihistamines, some patients may still experience drowsiness.
Contraindications[edit]
Acrivastine should not be used in individuals with known hypersensitivity to the drug or any of its components. Caution is advised in patients with renal impairment due to the drug's excretion through the kidneys.
